Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
iiMED was a U.S.-based medical device outsourcing and specialty manufacturing company focused on FDA Class I and II consumable medical devices. The company partnered with medical device OEMs on design-to-manufacturing services, with particular strength in nearshore production and value-added converting, sewing, lamination, and clean-room assembly. Its product and application areas included orthopedic bracing, sterile supplies, compression devices, patient mobility products, patient monitoring, and wound care. iiMED was founded in 2003 and headquartered in Amherst, New York, with a large manufacturing footprint including Morristown, Tennessee and operations in Mexico. In January 2022, iiMED was acquired by TEAM Technologies, which later rebranded as Cordica Medical in January 2026.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on iiMED Medical Solutions.